摘要:
Rapid melt tablets that dissolve and release an active component in the oral cavity are comprised of a pharmaceutical active ingredient such as dextromethorphan complexed with a resin that is effective in taste-masking the otherwise bitter taste of the active making it convenient for oral administration. The drug/resin-complexed particles can be coated with water swellable or water insoluble polymers to impart controlled release properties to the active ingredient. A rapid melt tablet also comprises diluents, sweeteners, flavors, disintegrants and other excipients to form granules that can be compressed into tablets at low pressure without the need for a binding agent.
摘要:
The present invention relates to a pharmaceutical dosage form, and methods and system for making the pharmaceutical dosage form. The pharmaceutical dosage form contains a first component and a second component sealed in a container, such as a packet or sachet, blister pack, and capsule. Machines and methods for making the pharmaceutical dosage form is also provided.
摘要:
A novel encapsulated product is provided and includes: at least one pharmaceutical; at least one compressible material; and at least one tableting material; wherein the encapsulated product is in the form of a caplet having a diameter of from about 1 millimeter to about 7 millimeters and a length from about 1 millimeter to about 7 millimeters. A method for preparing the encapsulated product is also provided.
摘要:
The present invention provides a novel rapid-melt pharmaceutical composition comprising a binder, a super emulsifier, a diluent/bulking material; and an active ingredient. The present invention also provides a rapid-melt bead composition comprising a binder having a melting point from about 20 to about 90° C., an emulsifier; a diluent/bulking material; and an active ingredient. Further, the present invention provides a chew tablet composition comprising a binder; an emulsifier having a melting point of greater than about 40° C.; a diluent/bulking material; and an active ingredient. Methods of making the disclosed compositions are also described.
摘要:
Modified or extended release formulations containing mesalamine compounds and associated methods are disclosed and described. In some aspects, such formulations may be substantially bioequivalent to known FDA approved mesalamine formulations such as PENTASA®.
摘要:
Solid dose rapidly disintegrating compositions for administering pharmaceutical and nutritional supplement agents and methods for the preparation thereof are disclosed and described. Preparation methods which maintain the particulate size of an active agent at the pre-processing size in the final composition are further disclosed. The ability to maintain such particulate size provides a number of advantages, including improved bioavailability and more accurate dosing.
摘要:
A novel rapid-melt, semi-solid molded composition including at least one binder in an amount from about 0.01% to about 70% by weight; a salivating agent in an amount from about 0.05% to about 15% by weight, a diluent/bulking material in an amount from about 10% to about 90% by weight; and an active material in an amount from about 0.001% to about 70% by weight. Further, the inventive subject matter includes a method of preparing a rapid-melt, semi-solid molded composition comprising the steps of: melting at least one binder in an amount from about 0.01% to about 70% by weight with a salivating agent in an amount from about 0.05% to about 15% by weight, to form a mixture; mixing an active material with said mixture to form an active mixture; mixing a diluent/bulking material with said active mixture to form a final mixture; and molding said final mixture into said semi-solid molded composition.
摘要:
In one embodiment, a method of a client device includes accessing an application through an application template. The application template resides on server device. The method also includes accessing application based on a response to request of a user interface. In addition, the method includes processing the application through a processor such that the application accesses the application template such that the client device permits an access of the application through the application template. The method further includes executing the application through the application template such that an execution of the application through the application template emulates the execution of the application installed on an operating system of the client device. The method also includes executing a function of the application template based on a demand of a user through the response to the request of the user such that the file is accessed when required by the application.
摘要:
A method and system of operating system independent cloud computing is provided. In one embodiment, a method of a client device includes accessing a first application through a first application template. The first application template resides on a server. The method also includes accessing the first application based on a response to a request of a user interface of the client device. Furthermore, the method includes processing the first application through a processor such that the first application accesses the first application template such that the client device permits an access of the first application through the first application template. The method also includes executing the first application through the first application template such that an execution of the first application through the first application template emulates the execution of the first application installed on an operating system of the client device.
摘要:
A novel encapsulated product is provided and includes: at least one pharmaceutical; at least one compressible material; and at least one tableting material; wherein the encapsulated product is in the form of a caplet having a diameter of from about 1 millimeter to about 7 millimeters and a length from about 1 millimeter to about 7 millimeters. A method for preparing the encapsulated product is also provided.